7
1 Toward integration of Clinical Care and Clinical Research: Brussels 10th and 11th March 2008 ORACLE Belgium Airport Business Center, Brussels Introduction to Day 2. Isabelle de Zegher March 11 th 2008

Introduction to Day 2. Isabelle de Zegher March 11 th 2008

  • Upload
    arien

  • View
    39

  • Download
    0

Embed Size (px)

DESCRIPTION

Toward integration of Clinical Care and Clinical Research: Brussels 10th and 11th March 2008 ORACLE Belgium Airport Business Center, Brussels. Introduction to Day 2. Isabelle de Zegher March 11 th 2008. Objective of Day 2. In alignment with the high level recommendations, - PowerPoint PPT Presentation

Citation preview

Page 1: Introduction to Day 2.  Isabelle de Zegher March 11 th  2008

1

Toward integration of Clinical Care

and Clinical Research: Brussels 10th and 11th March

2008ORACLE Belgium

Airport Business Center, Brussels Introduction to Day 2. Isabelle de Zegher

March 11th 2008

Page 2: Introduction to Day 2.  Isabelle de Zegher March 11 th  2008

2

Objective of Day 2

In alignment with the high level recommendations,

Define concrete proposals for implementation to be submitted to IMI and FP7,

under the form of strategic research agenda item – not precise project proposal !

as suggestion for inclusion in the forthcoming call for proposal (2009-2010).

These proposals – will be formally communicated to IMI and DG InfoSoc

Page 3: Introduction to Day 2.  Isabelle de Zegher March 11 th  2008

3

PlenaryTime Title Speaker

08:30 – 09:00(40 min)

Wrap Up from Day 1•Summary on discussion related to high level recommendation/political statement

•Any questions on IMI

I. Iakovidis

EFPIA/I. de Zegher

09:00 – 09:50 (50 min)

On-going FP7 projects related to safety (objectives, how does it link clinical care and “secondary” use of EHR data) •ALERT (25 min – J van der Lei)•DEBUG IT (25 min - D. Colaert/C. Lovis )

J. Van der LeiD. Colaert/C. Lovis

09:50 – 10:40 (60 min)

Objective, lessons learned and status of projects initiated in October •CRFQ (20 min – I. de Zegher)•Core data sets (20 min – G. Zahlman)•Third party assessment (20 min – G. Stadler)

I. de ZegherG. ZahlmanG. Stadler

Page 4: Introduction to Day 2.  Isabelle de Zegher March 11 th  2008

4

Time Title Speaker

10:40 – 11: 00(20 min)

BREAK

11:00 – 15:00 (4 hours including lunch)

Break out sessions per project. Division in 3 subgroups composed by participants from the 3 pilot projects + legal team

Specific actions agreed per project Identification of key items that should be included in strategic research agenda for IMI / FP7 – specification of objective, innovative component, contribution to objectives of IMI and FP7

Group & location specified in other slides

15:00 – 16:30(30 min)

Plenary and reporting Conclusions: Strategic research agenda items to be submitted as suggestion for inclusion in the forthcoming calls for proposal FP7/IMI(2009-2010).

E. Maurincomme I. de ZegherJ. Devlies

16:30 CLOSE OF WORKSHOP

Break out sessions

Page 5: Introduction to Day 2.  Isabelle de Zegher March 11 th  2008

5

Session 1 : CRFQ and Service frameworkChair : J. van der LeiRapporteur : I. de ZegherLocation : Room Ensor

Daniel (Le Bozec) ChristelAPHP / INSERM UMRS872 [email protected]

de Zegher Isabelle Novartis [email protected]

Iakovidis Ilias DG INFSO, ICT Health [email protected]

Lovis Christian CHU Geneva [email protected]

Mead Charlie Booz Allen Ham./NCI [email protected]

Perkins Richard eClinical Forum [email protected]

Rouault Stephane Hoffmann La Roche [email protected]

Stroetmann Veli Empirica [email protected]

Tardiff Barbara Parexel [email protected]

Tiffe Sven AGFA [email protected]

Twaites Rob GSK [email protected]

van der Lei Johan Erasmus U Rotterdam [email protected]

Wilson Petra Cisco [email protected]

Page 6: Introduction to Day 2.  Isabelle de Zegher March 11 th  2008

6

Session 2 : Core Data SetsChair : Pierre-Yves LasticRapporteur : G. ZahlmanLocation : Room Rubens

Andoulsi Isabelle Exelia Law Firm [email protected]

Colaert Dirk AGFA [email protected]

De Meyer Filip Eurorec [email protected]

Devlies Jos ProRec Belgium [email protected]

Kalra Dipak CHIME, UCL [email protected]

Lastic PY Sanofi [email protected]

Maurincomme Eric Agfa Healthcare [email protected]

Schwarz-Boeger Ulrike TU Munic [email protected]

Siegmann Udo Parexel [email protected]

Singleton Peter UCL [email protected]

Snowball Stan Merck [email protected]

Sundgren Mats Astra Zeneca [email protected]

Van Zeijl Gilbert University of Maastricht [email protected]

Zahlman Gudrun Siemens [email protected]

Page 7: Introduction to Day 2.  Isabelle de Zegher March 11 th  2008

7

Session 3 : Third Party/Information BrokerChair : G. StadlerRapporteur : L. SchildersLocation : Room Pauli

Bengstrom Mia Pharma Industry Finland [email protected]

Ferre Bernard EFPIA [email protected]

Heidenreich Karin Novartis [email protected]

Hilton Paul Pfizer [email protected]

Ohmann Christian KKS Düsseldorf [email protected]

Parkinson John MHRA, GPRD [email protected]

Payne Sarah IBM [email protected]

Samuel Jean Pfizer [email protected]

Schilders Louis Custodix [email protected]

Stadler Greg eLilly [email protected]

Thick Michael Connecting for Health, NHS [email protected]

Trower David IMS [email protected]